Published in Exp Biol Med (Maywood) on January 01, 2017
Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med (2010) 5.37
Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol (2005) 1.94
Hypersplenism. Bull N Y Acad Med (1955) 1.93
Partial splenic embolization in the treatment of hypersplenism. AJR Am J Roentgenol (1979) 1.88
Immune dysregulation, polyendocrinopathy, enteropathy, x-linked syndrome: a paradigm of immunodeficiency with autoimmunity. Front Immunol (2012) 1.51
Beta-Lactam antibiotic-induced leukopenia in severe hepatic dysfunction: risk factors and implications for dosing in patients with liver disease. Am J Med (1993) 1.46
Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease. Am J Gastroenterol (2000) 1.08
Laparoscopic splenectomy for hypersplenism secondary to liver cirrhosis and portal hypertension. World J Gastroenterol (2014) 1.02
Liver fibrosis is associated with decreased peripheral platelet count in patients with chronic hepatitis B and C. Dig Dis Sci (2007) 1.02
Current endoscopic therapy of variceal bleeding. Best Pract Res Clin Gastroenterol (2008) 1.00
A DPYD variant (Y186C) specific to individuals of African descent in a patient with life-threatening 5-FU toxic effects: potential for an individualized medicine approach. Mayo Clin Proc (2014) 0.99
Effects of splenomegaly and splenic macrophage activity in hypersplenism due to cirrhosis. Am J Med (2002) 0.97
Platelet autoantibodies in patients with chronic liver disease. Am J Hematol (1995) 0.96
Changes in platelet kinetics after a partial splenic arterial embolization in cirrhotic patients with hypersplenism. Hepatology (1995) 0.95
Thrombopoietin agonists for the treatment of thrombocytopenia in liver disease and hepatitis C. Clin Liver Dis (2009) 0.94
miR-615-3p promotes the phagocytic capacity of splenic macrophages by targeting ligand-dependent nuclear receptor corepressor in cirrhosis-related portal hypertension. Exp Biol Med (Maywood) (2011) 0.90
Oxaliplatin-induced immune hemolytic anemia: a case report and review of the literature. Anticancer Drugs (2007) 0.90
Hemophagocytic syndrome in Dengue hemorrhagic fever with severe multiorgan complications. J Med Assoc Thai (2008) 0.90
Thrombopoietin level in patients with chronic liver diseases. Ann Hepatol (2008) 0.86
Splenectomy in cirrhosis with hypersplenism: improvement in cytopenias, Child's status and institution of specific treatment for hepatitis C with success. Ann Hepatol (2012) 0.86
[Clinical usefulness of the simple technique to diagnose thrombocytopenia using immature platelet fraction]. Korean J Lab Med (2007) 0.86
Emergency sclerotherapy versus vasoactive drugs for bleeding oesophageal varices in cirrhotic patients. Cochrane Database Syst Rev (2010) 0.85
Severe gastric variceal bleeding successfully treated by emergency splenic artery embolization. Pediatr Int (2013) 0.85
Peripheral blood cell variations in cirrhotic portal hypertension patients with hypersplenism. Asian Pac J Trop Med (2013) 0.85
Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood. Hepatology (1999) 0.84
Regulation of hepatic thrombopoietin production by portal hemodynamics in liver cirrhosis. Am J Gastroenterol (1998) 0.84
Improving cytopenia with splenic artery embolization in a patient with paroxysmal nocturnal hemoglobinuria on eculizumab. Int J Hematol (2013) 0.82
Aplastica anemia and viral hepatitis. Mediterr J Hematol Infect Dis (2009) 0.81
Frequency of iron deficiency anemia in girls studying in mashhad high schools. Iran J Ped Hematol Oncol (2013) 0.81
The long-term effects of splenectomy and subsequent interferon therapy in patients with HCV-related liver cirrhosis. Mol Med Rep (2013) 0.80
Endotoxaemia in the pathogenesis of cytopenias in liver cirrhosis. Could oral antibiotics raise blood counts? Med Hypotheses (2010) 0.80
Thrombocytopenia associated with liver cirrhosis and hepatitis C viral infection: role of thrombopoietin. Hepatogastroenterology (2001) 0.80
[The significance of combined treatment for hepatocellular carcinoma with partial splenic embolization and transcatheter arterial chemoembolization using IA call/lipiodol]. Gan To Kagaku Ryoho (2008) 0.79
Cytopenia and autoimmune diseases: a vicious cycle fueled by mTOR dysregulation in hematopoietic stem cells. J Autoimmun (2013) 0.79
Partial splenic artery embolization for thrombocytopenia and uncontrolled massive ascites after liver transplantation. Transplant Proc (2012) 0.79
[Endoscopic rubber band ligation in treatment of esophageal varices bleeding. Personal experience]. G Chir (2011) 0.78
Clinical study on the relationship between hematocytopenia and splenomegaly caused by cirrhotic portal hypertension. Cell Biochem Biophys (2014) 0.78
[Splenomegaly and thrombocytopenia in patients with liver cirrhosis]. Vojnosanit Pregl (2010) 0.78
[Endoscopic ligation in treatment of advanced schistosomiasis patients with esophageal variceal bleeding: a report of 68 cases]. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi (2013) 0.77
Grading of peripheral cytopenias caused by nonalcoholic cirrhotic portal hypertension and its clinical significance. Cell Biochem Biophys (2015) 0.77
Effect of surgery treatment on hypersplenism caused by cirrhotic portal hypertension. Minerva Chir (2013) 0.77
[Study on primary hepatocellular carcinoma associated with hypersplenism treated by partial splenic embolization combined with hepatic arterial chemoembolization]. Ai Zheng (2006) 0.77
[Spleno-renal distal and proximal shunts for hypersplenism due to hepatic cirrhosis]. Chirurgia (Bucur) (2008) 0.77
Key factors of therapeutic effects for surgery in patients with cirrhotic portal hypertension. Eur Rev Med Pharmacol Sci (2015) 0.76
Hemodynamic effects of combined therapy using partial splenic embolization and transjugular retrograde obliteration for gastric varices with gastrorenal shunt. World J Surg (2010) 0.76
[Role of vitamin deficiency in pancytopenia in Djibouti. Findings in a series of 81 consectutive patients]. Med Trop (Mars) (2005) 0.76
[Clinical features and laboratory findings of adult Epstein-Barr virus associated T/NK lymphoproliferative disease]. Zhongguo Shi Yan Xue Ye Xue Za Zhi (2013) 0.76
[Beneficial effect of glucocorticosteroids for esophageal varices due to idiopathic portal hypertension following systemic lupus erythematosus]. Nihon Rinsho Meneki Gakkai Kaishi (2004) 0.76